The simple moving average for the past 20 days is -42.67% for RADX’s stock, with a -42.67% simple moving average for the past 200 days.
Is It Worth Investing in Radiopharm Theranostics Ltd ADR (NASDAQ: RADX) Right Now?
The average trading volume of RADX on December 27, 2024 was 61.05K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
RADX) stock’s latest price update
The stock price of Radiopharm Theranostics Ltd ADR (NASDAQ: RADX) has dropped by -2.68 compared to previous close of 4.10. Despite this, the company has seen a fall of -11.33% in its stock price over the last five trading days.
RADX Trading at -42.67% from the 50-Day Moving Average
After a stumble in the market that brought RADX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.15% of loss for the given period.
During the last 5 trading sessions, RADX fell by -11.33%, in comparison to the 20-day moving average. In addition, Radiopharm Theranostics Ltd ADR saw -77.42% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for RADX
Equity return is now at value -132.50, with -65.30 for asset returns.
The liquidity ratio also appears to be rather interesting for investors as it stands at 1.30.
Conclusion
In a nutshell, Radiopharm Theranostics Ltd ADR (RADX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
